Editors:
Covers all aspects of vaccines and other biologics employed for treatment of substance use disorders
Discusses novel strategies to optimize the development and efficacy of biologics
Written and edited by experts in the field
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (21 chapters)
-
Front Matter
-
Strategies to Optimize the Development of Biologics to Treat Addictions
-
Front Matter
-
About this book
This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions.
Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
Reviews
“The intended audience is psychiatrists, pharmacologists, immunologists, counselors, toxicologists, social workers, addiction specialists, and all medical professionals working with patients with drug addictions. … This is the first book, and a most comprehensive one, about the research and development of biologics to treat substance use disorders and overdose. Hopefully, biologics will be part of the therapeutic armamentarium that healthcare providers can use in the treatment of their patients with these disorders.” (Michael Easton, Doody's Book Reviews, June, 2016)
Editors and Affiliations
-
National Institute on Drug Abuse, National Institutes of Health, Bethesda, USA
Ivan D. Montoya
Bibliographic Information
Book Title: Biologics to Treat Substance Use Disorders
Book Subtitle: Vaccines, Monoclonal Antibodies, and Enzymes
Editors: Ivan D. Montoya
DOI: https://doi.org/10.1007/978-3-319-23150-1
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-23149-5Published: 06 January 2016
Softcover ISBN: 978-3-319-79451-8Published: 30 March 2018
eBook ISBN: 978-3-319-23150-1Published: 18 December 2015
Edition Number: 1
Number of Pages: XVI, 453
Number of Illustrations: 47 b/w illustrations, 57 illustrations in colour
Topics: Psychopharmacology, Pharmacotherapy, Pharmacology/Toxicology